Related Experiment Video
Updated: May 19, 2026

HOX Loci Focused CRISPR/sgRNA Library Screening Identifying Critical CTCF Boundaries
Published on: March 31, 2019
HDAC1/DNMT3A-containing complex is associated with suppression of Oct4 in cervical cancer cells
Dongbo Liu1, Peng Zhou, Li Zhang
1Department of Biochemistry and Molecular Biology, Third Military Medical University, 400038 Chongqing, China. liu.db1980@yahoo.com.cn
Abstract:
Octamer-binding transcription factor 4 (Oct4), an important embryonic transcriptional factor, is highly expressed in several tumors and is considered as a hallmark of cancer stem cells. Knowledge about the expression and regulatory mechanisms of Oct4 can contribute to the treatment of cancers. As for cervical cancer, however, details remain obscure about Oct4 expression and its regulatory mechanism. In this study, we found that the level of Oct4 in human papillomavirus 16 (HPV16)- positive cervical cancer cells (CaSki cells) was higher than that in HPV-negative cervical cancer cells (C-33A cells), whereas both the level of histone deacetylase 1 (HDAC1) and DNA methyltransferase 3A (DNMT3A) were lower in CaSki cells than those in C-33A cells. Treatment with valproic acid, an HDAC inhibitor, could significantly increase the expression of Oct4 in C-33A cells, but only slightly increased Oct4 in CaSki cells. Co-immunoprecipitation assays showed that HDAC1 and DNMT3A existed in a common complex. The co-immunoprecipitated DNMT3A or HDAC1 was dose-dependently decreased with valproic acid treatment. These results indicated that HDAC1/DNMT3A-containing complex is associated with the suppression of Oct4 in cervical cancer cells, and the activity of HDAC1 is required in the repression of Oct4.
Insights
Octamer-binding transcription factor 4 (Oct4) is elevated in HPV16-positive cervical cancer. A complex of histone deacetylase 1 (HDAC1) and DNA methyltransferase 3A (DNMT3A) suppresses Oct4, offering potential therapeutic targets.
Area of Science:
- Molecular Biology
- Cancer Research
- Epigenetics
Background:
- Octamer-binding transcription factor 4 (Oct4) is a key embryonic factor and a cancer stem cell marker.
- Understanding Oct4 regulation is crucial for cancer treatment, but its role in cervical cancer is unclear.
Purpose of the Study:
- To investigate the expression and regulatory mechanisms of Oct4 in cervical cancer.
- To determine the role of histone deacetylase 1 (HDAC1) and DNA methyltransferase 3A (DNMT3A) in Oct4 regulation.
Main Methods:
- Comparing Oct4, HDAC1, and DNMT3A levels in HPV16-positive (CaSki) and HPV-negative (C-33A) cervical cancer cells.
- Treating cells with valproic acid (an HDAC inhibitor) and assessing Oct4 expression.
- Utilizing co-immunoprecipitation assays to examine the interaction between HDAC1 and DNMT3A.
Main Results:
- Oct4 levels were higher in CaSki cells than C-33A cells.
- HDAC1 and DNMT3A levels were lower in CaSki cells compared to C-33A cells.
- Valproic acid increased Oct4 expression in C-33A cells but had a minor effect on CaSki cells.
- HDAC1 and DNMT3A form a complex that suppresses Oct4, and HDAC1 activity is essential for this repression.
Conclusions:
- The HDAC1/DNMT3A complex plays a significant role in suppressing Oct4 in cervical cancer.
- HDAC1 activity is necessary for the repression of Oct4 in cervical cancer cells.
- Targeting the HDAC1/DNMT3A complex may offer a novel therapeutic strategy for cervical cancer.
Related Concept Videos
Abnormal Proliferation
Inheritance of Chromatin Structures
lncRNA - Long Non-coding RNAs
Anaphase Promoting Complex
Heterochromatin
Constitutive heterochromatin: It is a highly compact region of chromatin that is mostly concentrated in the centromere and telomere. Unlike euchromatin, the amino acid at 9th...
Cadherins in Tissue Organization
Cell Sorting During Development
Cell sorting plays an...

